Board of Directors
Elected annually by our shareholders, the Board of Directors is the company's ultimate decision-making body. The directors select and monitor the performance of our senior executives on Bristol-Myers Squibb's Leadership Team, who are responsible for the day-to-day operation of the company. Directors also act as advisors and counselors to our senior management.
Chairman, Board of Directors, Bristol-Myers Squibb
Giovanni Caforio, M.D.
Chief Executive Officer, Bristol-Myers Squibb
Peter J. Arduini
President and Chief Executive Officer of Integra LifeSciences Holdings Corporation
Laurie H. Glimcher, M.D.
President & CEO, Dana-Farber Cancer Institute; Richard and Susan Smith Professor of Medicine, Harvard Medical School
Retired Vice Chairman of Ernst & Young LLP
Alan J. Lacy
Non-Executive Chairman, Dave & Buster's Entertainment, Inc.
Robert J. Bertolini
Former President and Chief Financial Officer of Bausch & Lomb
Matthew W. Emmens
Retired CEO and Chairman of Shire Pharmaceuticals
Theodore R. Samuels
Retired President of Capital Guardian Trust Company
Dinesh C. Paliwal
Executive Chairman, President and Chief Executive Officer, Harman International Industries, Inc.
Vicki L. Sato, Ph.D.
Professor of Management Practice, Harvard Business School
Gerald L. Storch
Chief Executive Officer, Hudson's Bay Company and Non-Executive Chairman, Supervalu, Inc.
Togo D. West, Jr.
Chairman, TLI Leadership Group